NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ — Evergreen Nephrology, a leader in value-based kidney care, today announced it has raised $130 million in capital to expand its care model to more patients living with kidney disease. Funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures. Funding will fuel Evergreen’s growth by enabling its expansion into new regions while implementing advanced technologies to improve clinical outcomes, streamline care delivery, and ease the administrative burden on nephrologists.

With over 37 million Americans living with chronic kidney disease and Medicare spending exceeding $95 billion annually, Evergreen’s value-based care approach addresses a critical need to transform how kidney disease is managed.

“This investment enables us to broaden access to care programs that improve patient outcomes while driving down healthcare costs,” said John Donlan, Chief Executive Officer of Evergreen Nephrology. “We are dedicated to creating lasting, positive change for patients and families affected by chronic kidney disease.”

“The healthcare system has long overlooked the critical need to empower nephrologists in the delivery of advanced kidney care management,” said Matt Kim, Partner at Rubicon and Co-Founder of Evergreen Nephrology. “By equipping nephrologists with the tools, resources, and support they need, Evergreen is bridging a crucial gap in healthcare and enabling a more effective, collaborative approach to managing kidney disease.”

Evergreen Nephrology takes a collaborative approach to kidney care by partnering closely with nephrologists to enhance patient outcomes. The organization offers nephrologists wraparound support through analytical insight and tools, and a dedicated care team for their patients consisting of nurse care managers, care coordinators, social workers, dietitians, and pharmacists. This interdisciplinary model ensures that patients receive holistic and personalized care while enabling nephrologists to focus on their clinical expertise and leadership in managing kidney disease.

Ropes & Gray LLP served as Evergreen’s legal counsel in connection with the transaction.

About Evergreen Nephrology

Evergreen Nephrology partners with nephrologists and payors to redefine kidney care for patients with chronic and end-stage kidney disease. Operating across 24 states with a network of over 900 providers, Evergreen delivers personalized, value-based care designed to empower patients and improve outcomes. Learn more at EvergreenNephrology.com.

Media Contact:
Corporate Communications
Evergreen Nephrology
media@evergreennephrology.com

SOURCE Evergreen Nephrology

Copyright © 2024 Cision US Inc.